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oston, Massachusetts
t is well established from post-mortem studies that rup-
ured atherosclerotic plaques in proximal coronary arteries
sually have a large necrotic core with a thin overlying
brous cap (1,2). These “thin cap fibroatheromas” usually
ave little calcification, and they may not cause critical
arrowing of the coronary lumen because of positive remod-
ling (outward expansion) of the artery. Intravascular ultra-
ound (IVUS) has also shown that, when compared with
atients with stable coronary artery disease, patients who
ecently had an acute coronary event showed more positive
emodeling and larger plaque areas (3).
See page 49
How can this important information be applied clinically?
ontrast-enhanced computed tomographic angiography
CTA) has emerged as a promising approach for the nonin-
asive assessment of coronary anatomy. It is useful in the
ecognition and characterization of congenital anomalies of the
oronary arteries and in determining the patency of coronary
rtery bypass grafts. CTA is becoming more widely employed
n the detection of coronary luminal narrowing in patients with
r suspected of having chronic coronary artery disease. It
ppears to be especially useful in ruling out obstructive disease
n patients with equivocal findings on clinical examination and
n stress myocardial perfusion scanning. It is likely that with
ontinuing improvement in accuracy, CTA will grow in
mportance for this application.
The use of contrast-enhanced CTA for the characteriza-
ion of coronary artery plaques is more challenging, and
ecause of its potential clinical importance, it has been the
ocus of attention of several research groups. Building on
he histologic and IVUS findings, and using multi-row
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.p
From the TIMI Study Group, Cardiovascular Division, Brigham and Women’s
ospital, Boston, Massachusetts.etectors, it has been demonstrated that contrast-enhanced
TA can provide measurements of plaque area and volume
4), and that it can be used to quantify plaque density, which
orrelates well with plaque echogenicity and composition
5). These findings, using contrast-enhanced CTA, corre-
ate with those obtained by IVUS (4,5).
Motoyama et al. (6) compared disrupted plaques in
atients who had experienced an acute coronary syn-
rome (ACS) with plaques obtained from patients with
table angina. As was the case with disrupted plaques
tudied by IVUS, disrupted plaques assessed by CTA also
howed positive vascular remodeling, low plaque density,
nd spotty calcification (6). In this issue of the Journal,
otoyama et al. (7) describe the next important step in
he clinical study of coronary atheroma. These investiga-
ors employed contrast-enhanced CTA to identify vul-
erable plaques that had not yet ruptured in patients who
ad not experienced an acute coronary event—in other
ords, before the horse had been stolen from the barn.
hey analyzed 10,037 coronary arterial segments in 1,059
atients with known or suspected coronary artery disease
or 2 of the features previously identified in plaques that
ave already ruptured, namely, positive coronary artery
emodeling and the presence of plaques exhibiting low
ttenuation (“soft”) plaques. Of the 1,059 patients stud-
ed, 15 (1.5%) had an ACS over a mean follow-up of 27
onths. The risk for an acute coronary event was quite
igh, namely, 22% in subjects with both of these features.
n ACS developed in 11% of subjects with either of the
features. Only 0.5% of the patients without either
eature had an acute coronary event, providing a strong
egative predictive value. The development of an acute
oronary event in 2 years could, for all practical purposes,
e excluded in 80% of patients with known or suspected
oronary artery disease.
In addition, and in accord with previous histologic and
VUS studies, Motoyama et al. (7) also found that spotty
alcification occurred more frequently and that total
laque volume and the ratio of low-attenuation plaque to
otal plaque area were both significantly higher in pa-
ients who subsequently had an ACS than in those who
id not. The positive remodeling prevented many of
hese enlarged vulnerable plaques from encroaching on
he coronary lumen. Thus, these plaques are often not
esponsible for either ischemic symptoms or impaired
yocardial perfusion during stress. That explains the
requent finding of the sudden, unheralded development
f ACS, and even sudden cardiac death, in previously
symptomatic patients.
Risk stratification for the development of ACS began
ith the well-established Framingham risk score (8),
hich has recently been refined by Ridker et al. (9) by
dding C-reactive protein and family history—the so-
alled Reynolds risk score. These scores can identify
atients who require intensive primary preventive mea-
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June 30, 2009:58–9 Detection of Vulnerable Plaquesures. How could detection of vulnerable plaques by CTA
t into the prevention scheme? It does not appear
ppropriate at this time to propose the use of CTA to
etect vulnerable plaques in patient populations such as
hose studied by Motoyama et al. (7). To be of clinical
alue, the procedure would probably have to be repeated
very 2 or 3 years. The costs of such an approach and the
urden of radiation exposure are both too high and the
ield too low to make this strategy clinically useful at
resent. However, this field is still in its infancy, and it is
afe to predict that the limitations noted in the preceding
ext will diminish in the next few years. Certainly, the
ew 320- and 256-detector row CT scanners are improv-
ng image quality and resolution (10,11), while the use of
ual-source CT is enhancing temporal resolution (12).
lso, a greater yield would clearly be obtained if patients
t higher risk of having an ACS than those studied by
otoyama et al. (7) had been investigated.
The widespread clinical application of the approach of
otoyama et al. (7) for the detection of vulnerable
laques at risk of future rupture (namely, locking the barn
oor before the horse is stolen) would require the
evelopment of measures for the prevention of plaque
upture that are more potent than those currently em-
loyed, in what we currently refer to as intensive preven-
ion. One measure could be the use of dual antiplatelet
herapy (aspirin and a thienopyridine), although the risk
f bleeding from the prolonged use must be considered.
erhaps stenting or surgically bypassing these plaques
ould be considered in some patients. Newer and more
otent anti-inflammatory drugs are in the developmental
tage, and if proved to be safe for long-term administra-
ion, they could be employed. Indeed, the ability to detect
hese vulnerable plaques noninvasively is likely to serve as
powerful stimulus for increased effort in the develop-
ent of such therapies (13). When more effective ther-
pies for these plaques do become available, the paper by
otoyama et al. (7) will be surely become a landmark inhe effort to prevent acute coronary events.
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